Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
(Q35022505)
scientific article
scientific article
Language:
Current Data About
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
other details
description | scientific article |
External Links
(P356) |
10.1038/SJ.ONC.1206081
|
(P698) |
12476300
|
(P5875) |
10996466
|
(P6179) |
1027675129
|